X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness

Cancer Genet Cytogenet. 1993 Oct 1;70(1):25-30. doi: 10.1016/0165-4608(93)90127-8.

Abstract

Frequencies of chromatid aberrations in response to G2-phase x-irradiation were compared in PHA-stimulated blood lymphocytes from healthy control subjects, Down syndrome (DS) patients, and Alzheimer disease (AD) patients. In cells arrested with Colcemid immediately (0-30 min) after x-irradiation, DS, AD, and control cells showed similar high frequencies of chromatid breaks and gaps, representing unrepaired DNA strand breaks. Frequencies had decreased in AD and control cells arrested 30-90 min after irradiation. However, DS cells had two- to three-fold higher frequencies than AD or control cells. This result indicates deficient repair of the DNA damage in DS cells. Similar responses were obtained with lymphocytes from four of seven DS parents tested and with skin fibroblasts from DS patients compared to age-matched controls. Addition of 1-beta-D-arabinofuranosylcytosine (ara-C), an inhibitor of the repair polymerase, after x-irradiation during G2 phase increased the frequencies of chromatid breaks and gaps in lymphocytes from control and AD donors significantly more than in those from DS patients. This result indicates a deficiency in DS cells in incision at sites of x-ray-induced damage. Thus DS, like other cancer-prone genetic disorders, has a G2-phase DNA repair deficiency in strand break repair and also a second DNA repair deficiency in incision activity.

MeSH terms

  • Adult
  • Aged
  • Alzheimer Disease / genetics*
  • Cell Cycle
  • Chromatids / radiation effects*
  • Cytarabine / pharmacology
  • DNA Damage*
  • DNA Repair* / drug effects
  • Down Syndrome / genetics*
  • Female
  • Humans
  • In Vitro Techniques
  • Interphase
  • Male
  • Middle Aged
  • Neoplasms / genetics
  • X-Rays

Substances

  • Cytarabine